The Bharat Biotech International Limited on Thursday announced the successful completion of volunteer enrolment for phase-3 clinical trials of its indigenously manufactured COVID-19 vaccine 'Covaxin.' ...
Serum Institute of India and Bharat Biotech jointly communicated their pledge on Tuesday for the smooth rollout of COVID-19 vaccines to India and the world. ...